LOCAL listed pharmaceutical company Biopharmica has announced successful results from work conducted by the Western Australian Institute for Medical Research (WAIMR) on a cancer gene.
LOCAL biomedical company BioPharmica intends to list on the Australian Stock Exchange and will go to the market in the coming weeks, aiming to raise $4.5 million.